<VariationArchive RecordType="classified" VariationID="4031" VariationName="NM_000152.5(GAA):c.2483_2646+1del" VariationType="Deletion" Accession="VCV000004031" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-03-18" DateCreated="2013-10-02" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19070" VariationID="4031">
      <GeneList>
        <Gene Symbol="GAA" FullName="alpha glucosidase" GeneID="2548" HGNC_ID="HGNC:4065" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="80101581" stop="80119881" display_start="80101581" display_stop="80119881" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NW_025791802.1" start="126287" stop="144587" display_start="126287" display_stop="144587" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="78075354" stop="78093678" display_start="78075354" display_stop="78093678" Strand="+" />
          </Location>
          <OMIM>606800</OMIM>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000152.5(GAA):c.2483_2646+1del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="80118193" stop="80118357" display_start="80118193" display_stop="80118357" variantLength="165" positionVCF="80118192" referenceAlleleVCF="GGGCCCTGGCCTCACAACCACAGAGTCCCGCCAGCAGCCCATGGCCCTGGCTGTGGCCCTGACCAAGGGTGGGGAGGCCCGAGGGGAGCTGTTCTGGGACGATGGAGAGAGCCTGGAAGTGCTGGAGCGAGGGGCCTACACACAGGTCATCTTCCTGGCCAGGAAT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="78091992" stop="78092156" display_start="78091992" display_stop="78092156" variantLength="165" positionVCF="78091991" referenceAlleleVCF="GGGCCCTGGCCTCACAACCACAGAGTCCCGCCAGCAGCCCATGGCCCTGGCTGTGGCCCTGACCAAGGGTGGGGAGGCCCGAGGGGAGCTGTTCTGGGACGATGGAGAGAGCCTGGAAGTGCTGGAGCGAGGGGCCTACACACAGGTCATCTTCCTGGCCAGGAAT" alternateAlleleVCF="G" />
      </Location>
      <OtherNameList>
        <Name>Exon 18 del</Name>
        <Name>EX18DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_673" sequenceAccession="LRG_673">
            <Expression>LRG_673:g.21639_21803del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.78091993_78092157del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.78091993_78092157del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.80118194_80118358del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.80118194_80118358del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009822.1" sequenceAccession="NG_009822" sequenceVersion="1" change="g.21639_21803del">
            <Expression>NG_009822.1:g.21639_21803del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000152.5" sequenceAccession="NM_000152" sequenceVersion="5" change="c.2483_2646+1del" MANESelect="true">
            <Expression>NM_000152.5:c.2483_2646+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079803.3" sequenceAccession="NM_001079803" sequenceVersion="3" change="c.2483_2646+1del">
            <Expression>NM_001079803.3:c.2483_2646+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001079804.3" sequenceAccession="NM_001079804" sequenceVersion="3" change="c.2483_2646+1del">
            <Expression>NM_001079804.3:c.2483_2646+1del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340127" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606800.0012" DB="OMIM" />
        <XRef Type="rs" ID="1555603048" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI reports the breakpoints for the deletion as defined by the GAA LSDB, GAA_00037</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000152.5(GAA):c.2483_2646+1del AND Glycogen storage disease, type II" Accession="RCV000004246" Version="7">
        <ClassifiedConditionList TraitSetID="1104">
          <ClassifiedCondition DB="MedGen" ID="C0017921">Glycogen storage disease, type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-03-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1998-03-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-10-02" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10737124</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7717400</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7881425</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7945303</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8990003</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301438</ID>
          <ID Source="BookShelf">NBK1261</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1104" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1936" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease, type II</ElementValue>
                <XRef ID="Glycogen+Storage+Disease+Type+2/3122" DB="Genetic Alliance" />
                <XRef ID="237967002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLYCOGENOSIS, GENERALIZED, CARDIAC FORM</ElementValue>
                <XRef Type="MIM" ID="232300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD II</ElementValue>
                <XRef Type="MIM" ID="232300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucosidase acid-1,4-alpha deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acid maltase deficiency disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aglucosidase alfa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha-1,4-glucosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardiomegalia glycogenica diffusa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deficiency of alpha-glucosidase</ElementValue>
                <XRef ID="124462004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deficiency of lysosomal alpha-glucosidase</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">POMPE DISEASE</ElementValue>
                <XRef Type="MIM" ID="232300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ACID ALPHA-GLUCOSIDASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="232300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen Storage Disease Type II (Pompe Disease)</ElementValue>
                <XRef ID="NBK1261" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AMD</ElementValue>
                <XRef Type="MIM" ID="232300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">GSD2</ElementValue>
                <XRef Type="MIM" ID="232300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2503" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pompe disease is classified by age of onset, organ involvement, severity, and rate of progression. Infantile-onset Pompe disease (IOPD; individuals with onset before age 12 months with cardiomyopathy) may be apparent in utero but more typically onset is at the median age of four months with hypotonia, generalized muscle weakness, feeding difficulties, failure to thrive, respiratory distress, and hypertrophic cardiomyopathy. Without treatment by enzyme replacement therapy (ERT), IOPD commonly results in death by age two years from progressive left ventricular outflow obstruction and respiratory insufficiency. Late-onset Pompe disease (LOPD; including: (a) individuals with onset before age 12 months without cardiomyopathy; and (b) all individuals with onset after age 12 months) is characterized by proximal muscle weakness and respiratory insufficiency; clinically significant cardiac involvement is uncommon.</Attribute>
                <XRef ID="NBK1261" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301438</ID>
                <ID Source="BookShelf">NBK1261</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2006">
                <ID Source="pmc">3110959</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Pompe.pdf</URL>
                <CitationText>American College of Medical Genetics ACT SHEET, Newborn Screening ACT Sheet- Pompe Disease (Glycogen Storage Disease type II), 2022</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Pompe-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Pompe disease: acid alpha-glucosidase deficiency, 2022</CitationText>
              </Citation>
              <XRef ID="365" DB="Orphanet" />
              <XRef ID="C0017921" DB="MedGen" />
              <XRef ID="MONDO:0009290" DB="MONDO" />
              <XRef Type="MIM" ID="232300" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24412" SubmissionDate="2017-10-20" DateLastUpdated="2017-10-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606800.0012_GLYCOGEN STORAGE DISEASE II" title="GAA, EX18DEL_GLYCOGEN STORAGE DISEASE II" />
        <ClinVarAccession Accession="SCV000024412" DateUpdated="2017-10-23" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Van der Kraan et al. (1994) reported that deletion of exon 18 of the GAA gene is a frequent mutation in Pompe disease (GSD2; 232300). Huie et al. (1994) found this mutation in patients with both infantile and adult forms of this disease. Vorgerd et al. (1998) found homozygosity for the exon 18 deletion in 2 affected sibs and an unrelated patient with adult-type GSD II.</Attribute>
              <Citation>
                <ID Source="PubMed">7945303</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7881425</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">10737124</ID>
              </Citation>
              <XRef DB="OMIM" ID="232300" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Boerkoel et al. (1995) found a deletion of exon 18 of the GAA gene in 3 unrelated compound heterozygous patients, 2 of whom were infants, and 1 an adult. The second mutation in each of these patients was different. The infants with Pompe disease were French Canadian and Dutch. The adult was a woman of German extraction who had first consulted her physician at age 39 years for progressive proximal muscle weakness and respiratory insufficiency. In retrospect, she could recall limitation in her activity as far back as early adulthood. In one of the infants, there was deletion of lys903 (606800.0007); in the other, there was a leu299-to-arg substitution (606800.0008). In the adult, the authors observed a T-to-G transversion at position -13 of intron 1 (606800.0006).</Attribute>
              <Citation>
                <ID Source="PubMed">7717400</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Although Kroos et al. (1995) found deletion of exon 18 in the infantile and adult forms of the disease, those homozygous for this mutation and heterozygous for this mutation in combination with deletion of 525T (606800.0014) had the infantile form of Pompe disease; however, patients with deletion of exon 18 or deletion of 525T in combination with transversion of T to G at position -13 (606800.0006) had the juvenile or the adult form, suggesting that the intronic mutation was a mild mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">8990003</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GAA" />
          </GeneList>
          <Name>GAA, EX18DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX18DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606800.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLYCOGEN STORAGE DISEASE II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="145463" SubmissionDate="2021-07-26" DateLastUpdated="2022-10-01" DateCreated="2013-10-02">
        <ClinVarSubmissionID localKey="NM_000152.3:c.2482_2646del|OMIM:232300" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000086727" DateUpdated="2022-10-01" DateCreated="2013-10-02" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="BookShelf">NBK1261</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>Exon 18 del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000152.3:c.2482_2646del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017921" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Abbrev="GeneReviews" Type="review">
          <ID Source="PubMed">20301438</ID>
          <ID Source="BookShelf">NBK1261</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB10045698</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="24412" TraitType="Disease" MappingType="Name" MappingValue="GLYCOGEN STORAGE DISEASE II" MappingRef="Preferred">
        <MedGen CUI="C0017921" Name="Glycogen storage disease, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="145463" TraitType="Disease" MappingType="XRef" MappingValue="C0017921" MappingRef="MedGen">
        <MedGen CUI="C0017921" Name="Glycogen storage disease, type II" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

